GlycoGenesys GLGS (formerly SafeScience SAFS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (7)	1/25/2004 6:20:32 PM
From: tuck	Read Replies (1) of 56

>>Thursday January 22, 5:47 pm ET WASHINGTON -(Dow Jones)- Elan Corp. said it intends to sell up to 3.3 million shares of GlycoGenesys Inc. (NasdaqSC:GLGS - News) common stock, according to a Schedule 13D filed Thursday with the Securities and Exchange Commission (News - Websites) . Elan Corp. beneficially owns 14.2 million common shares, a 23.5% stake, the filing said. GlycoGenesys develops and licenses biotechnology products. The company recently registered 15.76 million common shares on behalf of some shareholders under a shelf filing with the SEC. The company and Elan ended a joint venture in December 2002.<< Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next